You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

CLINICAL TRIALS PROFILE FOR CARMOTEROL

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Carmoterol

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00605891 ↗	Dose Finding Study of CHF 4226 for Treating Patients With COPD	Completed	Chiesi Pharmaceuticals Inc.	Phase 2	The purpose of this study is to identify the optimal once-daily dose of CHF 4226 to be further developed for the treatment of patients with COPD.
NCT00605891 ↗	Dose Finding Study of CHF 4226 for Treating Patients With COPD	Completed	Chiesi Farmaceutici S.p.A.	Phase 2	The purpose of this study is to identify the optimal once-daily dose of CHF 4226 to be further developed for the treatment of patients with COPD.
NCT00640484 ↗	Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD	Completed	Chiesi Pharmaceuticals Inc.	Phase 2	The purpose of this study is to confirm the dose of CHF 4226 (carmoterol) that should be given once a day to patients with COPD in order for the effect to last for 24 hours.
NCT00640484 ↗	Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD	Completed	Chiesi Farmaceutici S.p.A.	Phase 2	The purpose of this study is to confirm the dose of CHF 4226 (carmoterol) that should be given once a day to patients with COPD in order for the effect to last for 24 hours.
NCT00777595 ↗	Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy Volunteers	Completed	Chiesi Pharmaceuticals Inc.	Phase 1	The purpose of this study is to evaluate the effect of single doses of therapeutic and supratherapeutic doses of inhaled CHF 4226 pMDI on ventricular repolarization in healthy subjects compared with placebo.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Carmoterol

Condition Name

Chart
Table

Condition Name
Intervention	Trials
Chronic Obstructive Pulmonary Disease	4
Asthma	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH
Intervention	Trials
Lung Diseases	4
Pulmonary Disease, Chronic Obstructive	4
Lung Diseases, Obstructive	4
Asthma	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Carmoterol

Trials by Country

Map
Table

Trials by Country
Location	Trials
United States	33
South Africa	2
Germany	1
Czech Republic	1
Romania	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State
Location	Trials
South Carolina	3
Oregon	3
Ohio	3
Florida	3
Texas	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Carmoterol

Clinical Trial Phase

Chart
Table

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 2	4
Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Carmoterol

Sponsor Name

Chart
Table

Sponsor Name
Sponsor	Trials
Chiesi Farmaceutici S.p.A.	5
Chiesi Pharmaceuticals Inc.	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type
Sponsor	Trials
Industry	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.